Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Battelle Memorial Institute

This article was originally published in Start Up

Executive Summary

Preeminent contract research organization Battelle is moving away from its image as a stodgy think tank and becoming more market-sensitive. While about 80% of its work is government oriented, the remainder has shifted from small, spot problem-solving projects toward those which are broader in scope--a value- and risk-sharing model where Battelle contributes resources and capital in exchange for royalties and, in some cases, equity in a start-up. Two such examples are Battelle Pulmonary Therapeutics (proprietary drug delivery technologies) and OmniViz (data mining software), both of which were incubated for several years within Battelle before being spun out.

Related Content





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts